Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Recs

0
Player Avatar modestus1 (< 20) Submitted: 6/3/2011 12:52:58 AM : Outperform Start Price: $2.14 OREX Score: +54.11

Friday's announcement

Featured Broker Partners


Advertisement